After BRCA1 and BRCA2—What Next? Multifactorial Segregation Analyses of Three-Generation, Population-Based Australian Families Affected by Female Breast Cancer-Reference-Cited by-同舟云学术

After BRCA1 and BRCA2—What Next? Multifactorial Segregation Analyses of Three-Generation, Population-Based Australian Families Affected by Female Breast Cancer

Published:2001-02 Issue:2 Volume:68 Page:420-431
ISSN:0002-9297
Container-title:The American Journal of Human Genetics
language:en
Short-container-title:The American Journal of Human Genetics

Author:

Cui Jisheng,Antoniou Antonis C.,Dite Gillian S.,Southey Melissa C.,Venter Deon J.,Easton Douglas F.,Giles Graham G.,McCredie Margaret R.E.,Hopper John L.

Publisher

Elsevier BV

Subject

Genetics (clinical),Genetics

Reference42 articles.

1. A new look at the statistical model identification;Akaike;IEEE Trans Automatic Control AU,1974

2. Antoniou AC, Pharoah PDP, McMullan G, Day NE, Ponder BAJ, Easton DF. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol (in press)

3. Breast cancer in Australian women 1982-1996;Australian Institute of Health and Welfare,1999

4. Genetic epidemiology of breast cancer: segregation analysis of 389 Icelandic pedigrees;Baffoe-Bonnie;Genet Epidemiol,2000

5. Absolute risk;Benichou,1997

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk prediction;The American Journal of Human Genetics;2022-10

2. Segregation analysis of 17,425 population-based breast cancer families: evidence for genetic susceptibility and risk prediction;2022-05-25

3. Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population;Frontiers in Oncology;2021-12-01

4. Uptake of Family-Specific Mutation Genetic Testing Among Relatives of Patients with Ovarian Cancer with BRCA1 or BRCA2 Mutation;Cancer Research and Treatment;2021-01-15

5. Clustering of known low and moderate risk alleles rather than a novel recessive high‐risk gene in non‐ BRCA1 /2 sib trios affected with breast cancer;International Journal of Cancer;2020-05-30